Original Research
Accepted on 29 Aug 2024
TAS-102 (trifluridine/tipiracil) plus Bevacizumab versus TAS-102 alone as Salvage Treatment Options for Metastatic Colorectal Cancer in Routine Clinical Practice
in Gastrointestinal Cancers: Colorectal Cancer